In this webinar, Dr. Philip Tiller reviews Metabolites in Safety Testing (MIST) and discusses the scientific foundation of our analytical approach. Finally Dr. Tiller shares a case study of our success.
Register to gain access to gated resources.
Thank you for registering!
You may now view the resource below.
Gene therapy holds the promise to transform medicine and creates options for patients who are living with incurable diseases. The industry has been booming in the last 20 years. Before a gene therapy product can be used in humans, the product must be tested for safety and effectiveness. This webinar focuses on the introduction of three critical test methods: AUC, Infectivity and RCL assays. Newly released FDA draft guidance for Industry on human gene therapy products will also be discussed.
In this white paper, we provide an overview of how CROs can support the analysis of biologics with an emphasis on in-depth structural elucidation, product release requirements, and stability testing (including degradation pathway studies).
Ensure comprehensive product analysis with Frontage’s team of experienced analytical scientists. We specialize in analytical method development, validation and transfer for product development and clinical trial materials (CTM) manufacturing support, as well as commercial product release and stability testing. Our services are designed to help sponsors throughout the drug development process in their effort to fully characterize drug substances, developmental formulations and commercial drug products.